Impact of sarcopenia on survival in patients undergoing living donor liver transplantation

American Journal of Transplantation

Volumn 13, Issue 6, 2013, Pages 1549-1556

  Kaido, T ^a   Ogawa, K ^a   Fujimoto, Y ^a   Ogura, Y ^a   Hata, K ^a   Ito, T ^a   Tomiyama, K ^a   Yagi, S ^a   Mori, A ^a   Uemoto, S ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Body cell mass; liver transplantation; nutritional therapy; sarcopenia; skeletal muscle mass

Indexed keywords

BRANCHED CHAIN AMINO ACID; GLUTAMINE; OLIGOSACCHARIDE; POLAPREZINC; PROBIOTIC AGENT; TYROSINE;

ADULT; ARTICLE; CONTROLLED STUDY; DIET THERAPY; DIETARY FIBER; FEMALE; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; SARCOPENIA; SKELETAL MUSCLE; SURGICAL MORTALITY; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; JAPAN; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOPENIA; SURVIVAL RATE;

EID: 84878481801     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12221     Document Type: Article

References (40)

1. Helton WS., Nutritional issues in hepatobiliary surgery. Semin Liver Dis 1994; 14: 140-157.
2. Pikul J, Sharpe MD, Lowndes R, Ghent CN., Degree of preoperative malnutrition is predictive of postoperative morbidity in liver transplant recipients. Transplantation 1994; 57: 469-472.
3. Selberg O, Böttcher J, Tusch G, Pichlmayr R, Henkel E, Müller MJ., Identification of high-and low-risk patients before liver transplantation: A prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997; 25: 625-657.
4. Sanchez AJ, Aranda-Michel J., Nutrition for the liver transplant patient. Liver Transplant 2006; 12: 1310-1316.
5. Stickel F, Inderbitzin D, Candinas D., Role of nutrition in liver transplantation for end-stage chronic liver disease. Nutr Rev 2008; 66: 47-54.
6. Anderson LJ, Erceg DN, Schroeder ET., Unity of multifrequency bioelectrical impedance compared with dual-energy X-ray absorptiometry for assessment of total and regional body composition varies between men and women. Nutr Res 2012; 32: 479-485.
7. Hoyle GE, Chua M, Soiza RL., Volaemic assessment of the elderly hyponatraemic patient: Reliability of clinical assessment and validation of bioelectrical impedance analysis. QJM 2011; 104: 35-39.
8. Jensky-Squires NE, Dieli-Conwright CM, Rossuello A, et al. Validity and reliability of body composition analysers in children and adults. Br J Nutr 2008; 100: 859-865.
9. Erceg DN, Dieli-Conwright CM, Rossuello A, Jensky NE, Sun S, Schroeder ET., The Stayhealthy bioelectrical impedence analyzer predicts body fat in children and adults. Nutr Res 2010; 30: 297-304.
10. Chertow GM, Lowrie EG, Wilmore DW, et al. Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol 1995; 6: 75-81.
11. Moore FD, Olsen KH, McMurrey JD, Parker HV, Ball MC, Boyden CM, eds. The body cell mass and its supporting environment. In: Body composition analysis in health and disease. Philadelphia: W.B. Saunders, 1963, pp. 1484-1508.
12. Wang Z, St-Onge MP, Lecumberri B, et al. Body cell mass: model development and validation at the cellular level of body composition. Am J Physiol Endocrinol Metab 2004; 286: E123-E128.
13. Pirlich M, Schutz T, Spachos S, et al. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000; 32: 1208-1215.
14. Kawaguchi T, Taniguchi E, Itou M, et al. Body cell mass is a useful parameter for assessing malnutrition and severity of disease in non-ascitic cirrhotic patients with hepatocellular carcinoma or esophageal varices. Int J Mol Med 2008; 22: 589-594.
15. Kaido T, Mori A, Ogura Y, et al. Pre- and perioperative factors affecting infection after living donor liver transplantation. Nutrition 2012; 28: 1104-1108.
16. Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008; 12: 433-450.
17. Evans W., Functional and metabolic consequences of sarcopenia. J Nutr 1997; 127 (5 Suppl): 998S-1003S.
18. Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M., Sarcopenic obesity: A Critical appraisal of the current evidence. Clin Nutr 2012; 31: 583-601.
19. Peng PD, van Vledder MG, Tsai S, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford) 2011; 13: 439-446.
20. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN., Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 2012; 99: 550-557.
21. Peng P, Hyder O, Firoozmand A, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 2012; 16: 1478-1486.
22. Hayashi F, Momoki C, Yuikawa M, et al. Nutritional status in relation to lifestyle in patients with compensated viral cirrhosis. World J Gastroenterol 2012; 18: 5759-5770.
23. Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010; 211: 271-278.
24. Mika C, Herpertz-Dahlmann B, Heer M, Holtkamp K., Improvement of nutritional status as assessed by multifrequency BIA during 15 weeks of refeeding in adolescent girls with anorexia nervosa. J Nutr 2004; 134: 3026-3030.
25. Inomata Y, Uemoto S, Asonuma K, Egawa H., Right lobe graft in living donor liver transplantation. Transplantation 2000; 69: 258-264.
26. Ito T, Kiuchi T, Egawa H, et al. Surgery-related morbidity in living donors of right-lobe liver graft: Lessons from the first 200 cases. Transplantation 2003; 76: 158-163.
27. Morioka D, Egawa H, Kasahara M, et al. Outcomes of adult-to-adult living donor liver transplantation: A single institution's experience with 335 consecutive cases. Ann Surg 2007; 245: 315-325.
28. Inomata Y, Tanaka K, Egawa H, et al. The evolution of immunosuppression with FK 506 in pediatric living related liver transplantation. Transplantation 1996; 61: 247-252.
29. Egawa H, Ohdan H, Haga H, et al. Current status of liver transplantation across ABO blood-type barrier. J Hepatobiliary Pancreat Surg 2008; 15: 131-138.
30. Plauth M, Cabré E, Riggio O, et al. ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 2006; 25: 285-294.
31. Tandon P, Ney M, Irwin I, et al. Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value. Liver Transpl 2012; 18: 1209-1216.
32. Kaido T, Egawa H, Tsuji H, Ashihara E, Maekawa T, Uemoto S., In-hospital mortality in adult recipients of living donor liver transplantation: Experience of 576 consecutive cases at a single center. Liver Transpl 2009; 15: 1420-1425.
33. Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 166-173.
34. Delmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 2007; 55: 769-774.
35. Chien MY, Huang TY, Wu YT., Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc 2008; 56: 1710-1715.
36. Janssen I, Heymsfield SB, Ross R., Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889-896.
37. Kaido T, Mori A, Ogura Y, et al. Impact of enteral nutrition using a new immuno-modulating diet after liver transplantation. Hepatogastroenterology 2010; 57: 1522-1525.
38. Kaido T, Ogura Y, Hata K, Yoshizawa A, Yagi S, Uemoto S., Effects of posttransplant enteral nutrition with an immunomodulating diet containing hydrolyzed whey peptide after liver transplantation. World J Surg 2012; 36: 1666-1671.
39. Yoshida R, Yagi T, Sadamori H, et al. Branched-chain amino acid-enriched nutrients improve nutritional and metabolic abnormalities in the early post-transplant period after living donor liver transplantation. J Hepatobiliary Pancreat Sci 2012; 19: 438-448.
40. Plank LD, McCall JL, Gane EJ, et al. Pre- and postoperative immunonutrition in patients undergoing liver transplantation: A pilot study of safety and efficacy. Clin Nutr 2005; 24: 288-296.